Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus-Like Particles in Human Immunodeficiency Virus (HFV)-Positive and High-Risk HIV-Negative Women

Raphael P. Viscidi, Linda Ahdieh-Grant, Michael F. Schneider, Barbara Clayman, L. Stewart Massad, Kathryn Anastos, Robert D. Burk, Howard Minkoff, Joel Palefsky, Alexandra Levine, Howard Strickler

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Serum samples from 2008 human immunodeficiency virus (HIV)-positive and 551 HIV-negative women were tested for immunoglobulin A (IgA) to human papillomavirus (HPV) type 16 capsids. IgA seropositivity was lower than previously reported IgG seropositivity (7% vs. 51%), but, like IgG antibodies, HPV 16 IgA was associated with sexual behavior, cervicovaginal HPV 16 DNA, and cytological abnormalities. IgA seropositivity was higher in HIV-positive women than in HIV-negative women (7.7% vs. 4.9%; P = .02), but the association was lost after adjustment for HPV 16 cervicovaginal infection. IgA, but not IgG, seropositivity was associated with progression to high-grade cytological abnormalities (relative hazard [RH], 2.2 [95% confidence interval, 1.2-4.2]), raising the possibility that an IgA response to HPV 16, as described for other DNA viruses, may be a marker of persistent viral replication. The risk of incident infection with non-16-related HPV types was increased in IgA seropositive women (RH, 1.8 [95% confidence interval, 1.3-2.6]), compared with seronegative women (RH, 2.2 [95% confidence interval, 0.9-5.4]), but there was no difference in the risk of incident HPV 16 or HPV 16-related infections. This may be evidence of partial type-specific or clade-specific immunity conferred by seropositivity to HPV 16 capsids.

Original languageEnglish (US)
Pages (from-to)1834-1844
Number of pages11
JournalJournal of Infectious Diseases
Volume188
Issue number12
DOIs
StatePublished - Dec 15 2003

Fingerprint

Human papillomavirus 16
Virion
Immunoglobulin A
HIV
Serum
Immunoglobulin G
Capsid
Confidence Intervals
Infection
DNA Viruses
Sexual Behavior
Immunity
Biomarkers
Antibodies
DNA

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus-Like Particles in Human Immunodeficiency Virus (HFV)-Positive and High-Risk HIV-Negative Women. / Viscidi, Raphael P.; Ahdieh-Grant, Linda; Schneider, Michael F.; Clayman, Barbara; Massad, L. Stewart; Anastos, Kathryn; Burk, Robert D.; Minkoff, Howard; Palefsky, Joel; Levine, Alexandra; Strickler, Howard.

In: Journal of Infectious Diseases, Vol. 188, No. 12, 15.12.2003, p. 1834-1844.

Research output: Contribution to journalArticle

Viscidi, Raphael P. ; Ahdieh-Grant, Linda ; Schneider, Michael F. ; Clayman, Barbara ; Massad, L. Stewart ; Anastos, Kathryn ; Burk, Robert D. ; Minkoff, Howard ; Palefsky, Joel ; Levine, Alexandra ; Strickler, Howard. / Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus-Like Particles in Human Immunodeficiency Virus (HFV)-Positive and High-Risk HIV-Negative Women. In: Journal of Infectious Diseases. 2003 ; Vol. 188, No. 12. pp. 1834-1844.
@article{5963c35b02a346d0b617b813ce2f316c,
title = "Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus-Like Particles in Human Immunodeficiency Virus (HFV)-Positive and High-Risk HIV-Negative Women",
abstract = "Serum samples from 2008 human immunodeficiency virus (HIV)-positive and 551 HIV-negative women were tested for immunoglobulin A (IgA) to human papillomavirus (HPV) type 16 capsids. IgA seropositivity was lower than previously reported IgG seropositivity (7{\%} vs. 51{\%}), but, like IgG antibodies, HPV 16 IgA was associated with sexual behavior, cervicovaginal HPV 16 DNA, and cytological abnormalities. IgA seropositivity was higher in HIV-positive women than in HIV-negative women (7.7{\%} vs. 4.9{\%}; P = .02), but the association was lost after adjustment for HPV 16 cervicovaginal infection. IgA, but not IgG, seropositivity was associated with progression to high-grade cytological abnormalities (relative hazard [RH], 2.2 [95{\%} confidence interval, 1.2-4.2]), raising the possibility that an IgA response to HPV 16, as described for other DNA viruses, may be a marker of persistent viral replication. The risk of incident infection with non-16-related HPV types was increased in IgA seropositive women (RH, 1.8 [95{\%} confidence interval, 1.3-2.6]), compared with seronegative women (RH, 2.2 [95{\%} confidence interval, 0.9-5.4]), but there was no difference in the risk of incident HPV 16 or HPV 16-related infections. This may be evidence of partial type-specific or clade-specific immunity conferred by seropositivity to HPV 16 capsids.",
author = "Viscidi, {Raphael P.} and Linda Ahdieh-Grant and Schneider, {Michael F.} and Barbara Clayman and Massad, {L. Stewart} and Kathryn Anastos and Burk, {Robert D.} and Howard Minkoff and Joel Palefsky and Alexandra Levine and Howard Strickler",
year = "2003",
month = "12",
day = "15",
doi = "10.1086/379975",
language = "English (US)",
volume = "188",
pages = "1834--1844",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus-Like Particles in Human Immunodeficiency Virus (HFV)-Positive and High-Risk HIV-Negative Women

AU - Viscidi, Raphael P.

AU - Ahdieh-Grant, Linda

AU - Schneider, Michael F.

AU - Clayman, Barbara

AU - Massad, L. Stewart

AU - Anastos, Kathryn

AU - Burk, Robert D.

AU - Minkoff, Howard

AU - Palefsky, Joel

AU - Levine, Alexandra

AU - Strickler, Howard

PY - 2003/12/15

Y1 - 2003/12/15

N2 - Serum samples from 2008 human immunodeficiency virus (HIV)-positive and 551 HIV-negative women were tested for immunoglobulin A (IgA) to human papillomavirus (HPV) type 16 capsids. IgA seropositivity was lower than previously reported IgG seropositivity (7% vs. 51%), but, like IgG antibodies, HPV 16 IgA was associated with sexual behavior, cervicovaginal HPV 16 DNA, and cytological abnormalities. IgA seropositivity was higher in HIV-positive women than in HIV-negative women (7.7% vs. 4.9%; P = .02), but the association was lost after adjustment for HPV 16 cervicovaginal infection. IgA, but not IgG, seropositivity was associated with progression to high-grade cytological abnormalities (relative hazard [RH], 2.2 [95% confidence interval, 1.2-4.2]), raising the possibility that an IgA response to HPV 16, as described for other DNA viruses, may be a marker of persistent viral replication. The risk of incident infection with non-16-related HPV types was increased in IgA seropositive women (RH, 1.8 [95% confidence interval, 1.3-2.6]), compared with seronegative women (RH, 2.2 [95% confidence interval, 0.9-5.4]), but there was no difference in the risk of incident HPV 16 or HPV 16-related infections. This may be evidence of partial type-specific or clade-specific immunity conferred by seropositivity to HPV 16 capsids.

AB - Serum samples from 2008 human immunodeficiency virus (HIV)-positive and 551 HIV-negative women were tested for immunoglobulin A (IgA) to human papillomavirus (HPV) type 16 capsids. IgA seropositivity was lower than previously reported IgG seropositivity (7% vs. 51%), but, like IgG antibodies, HPV 16 IgA was associated with sexual behavior, cervicovaginal HPV 16 DNA, and cytological abnormalities. IgA seropositivity was higher in HIV-positive women than in HIV-negative women (7.7% vs. 4.9%; P = .02), but the association was lost after adjustment for HPV 16 cervicovaginal infection. IgA, but not IgG, seropositivity was associated with progression to high-grade cytological abnormalities (relative hazard [RH], 2.2 [95% confidence interval, 1.2-4.2]), raising the possibility that an IgA response to HPV 16, as described for other DNA viruses, may be a marker of persistent viral replication. The risk of incident infection with non-16-related HPV types was increased in IgA seropositive women (RH, 1.8 [95% confidence interval, 1.3-2.6]), compared with seronegative women (RH, 2.2 [95% confidence interval, 0.9-5.4]), but there was no difference in the risk of incident HPV 16 or HPV 16-related infections. This may be evidence of partial type-specific or clade-specific immunity conferred by seropositivity to HPV 16 capsids.

UR - http://www.scopus.com/inward/record.url?scp=9144273194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144273194&partnerID=8YFLogxK

U2 - 10.1086/379975

DO - 10.1086/379975

M3 - Article

VL - 188

SP - 1834

EP - 1844

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 12

ER -